Who is sponsoring NCT01555151?

NCT01555151 is sponsored by Novartis Pharmaceuticals.

What drugs are being tested in NCT01555151?

Interventions: Mometasone furoate, Concept 1, Twisthaler.

What is the status of NCT01555151?

NCT01555151 is currently COMPLETED.

Last reviewed 2015-04-10 · How we verify

A Randomized, Double-blind, Double-dummy, 4-week Treatment, Parallel-group Study to Evaluate the Efficacy and Safety of Two Doses of Mometasone Furoate Delivered Via Concept1 or Twisthaler® in Adult and Adolescent Patients With Persistent Asthma

NCT01555151 Phase 2 COMPLETED Results posted

The purpose of this study is to compare the efficacy, safety and pharmacokinetics of Mometasone furoate delivered via Concept1 device or Twisthaler® device in adult and adolescent patients with persistent asthma.

Details

Lead sponsor	Novartis Pharmaceuticals
Phase	Phase 2
Status	COMPLETED
Enrolment	739
Start date	2012-07
Completion	2013-07

Conditions

Asthma

Interventions

Mometasone furoate
Concept 1
Twisthaler

Primary outcomes

Trough Forced Expiratory Volume in 1 Second (FEV1) — Day 29
Forced Expiratory Volume in 1 second (FEV1) was measured via spirometry conducted according to internationally accepted standards. Measurements were taken on day 29 after treatment.

Countries

Belgium, Canada, Estonia, Germany, Hungary, India, Japan, Latvia, Lithuania, Malaysia, Netherlands, Poland, Russia, Slovakia, Thailand, Turkey (Türkiye), Ukraine